ALL PRODUCTS • New Product Search (beta) : abilify 

Abilify

From the author of Toxic Psychiatry and Talking Back to Prozac :. "Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families.". -- Bertram Karon , Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia. "Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the correct psychiatric thinking more evident than in the books by Peter Breggin.". -- William Glasser , MD, psychiatrist, author of Reality Therapy. In Brain Disabling Treatments in Psychiatry , renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote. Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice. This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good.: New scientific analyses in this completely updated edition include:.; Chapters covering every new antidepressant and stimulant drug.; Twenty new guideli

From the author of Toxic Psychiatry and Talking Back to Prozac: "Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families." --Bertram Karon, Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia "Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the correct psychiatric thinking more evident than in the books by Peter Breggin." -- William Glasser, MD, psychiatrist, author of Reality Therapy In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote. Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice. This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good. New scientific analyses in this completely updated edition include: Chapters covering every new antidepressant and stimulant drug Twenty new guidelines for how to conduct non-drug therapy A chapter describing how to safely withdraw from psychiatric drugs A discussion of "medication spellbinding," explaining how patients fail to appreciate their drug-induced mental dysfunctions Documentation of how the drug companies control research and the flow of information about psychiatric treatments

This book of practical handouts is an essential resource for psychiatrists, pediatricians, and others who prescribe medicine for youth with behavioral and emotional problems. Written in language that lay readers--parents, teachers, and youth--can understand, this book covers today's most effective medications for pediatric behavioral and emotional disorders. This time-saving resource offers essential information for the patient, family, and school, including 64 medications from alprazolam to zolpidem. Each entry contains the basic information needed to reinforce clinical discussions, ensure that key points aren't forgotten or overlooked, and provide answers to important questions that arise between visits. Now in its third edition, this handy treatment aid has been restructured to enhance clinical use. The book is organized by generic drug name, with brand names indicated and indexed. Each medication has a handout for adults - parents and teachers - and a separate handout for youth. Each parent and teacher handout describes how the medication works, how long its effects last, some of the side effects and interactions with other medications and foods, and what could happen if the medication is stopped suddenly. Each medication handout for youth explains how to take the medication, how the doctor will follow patients' progress, and how the medication might affect patients. The clinician can photocopy handouts from the book or conveniently print them from the accompanying CD-ROM. Written by experienced clinicians, all medication information has been updated and new medications have been added. This fully enhanced third edition features Information on new medications such as atomoxetine (Strattera) and aripiprazole (Abilify) Explanations of new concerns about potential side effects and FDA black box warnings for antidepressants and stimulants Expanded coverage of medications for sleep Appendixes that list medications typically used for certain indications, to enable the clinician to discuss options with the family or to check off medications that have been tried Additional sources of information for the clinician and for patients and their families, including books, Web sites, and helpful organizations Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems, Third Edition, is a valuable resource that will help busy clinicians promote understanding, enhance compliance, and improve therapeutic outcomes.